# Intranasal Ketamine for Acute Traumatic Pain

> **NCT02817477** · PHASE4 · COMPLETED · sponsor: **Tel Aviv Medical Center** · enrollment: 90 (actual)

## Conditions studied

- Acute Pain

## Interventions

- **DRUG:** Ketamine Hydrochloride
- **DRUG:** Morphine

## Key facts

- **NCT ID:** NCT02817477
- **Lead sponsor:** Tel Aviv Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2016-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02817477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02817477, "Intranasal Ketamine for Acute Traumatic Pain". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02817477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*